Patent · US Expired

Bradykinin antagonists

US5843900A · kind A · utility

22Cited by
3References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 1995
Grant dateDec 1, 1998
Priority date
Expiry dateJun 5, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/816
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutically effective heterodimers comprising a bradykinin antagonist component covalently linked to a mu-opioid agonist component.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.